Evidence mapPaperPMID 28288974Full record

Trial reportJournal of the American Heart Association2017

China Stroke Primary Prevention Trial: Visit-to-Visit Systolic Blood Pressure Variability Is an Independent Predictor of Primary Stroke in Hypertensive Patients.

Xi Men, Wei Sun, Fangfang Fan, Min Zhao, Xiao Huang, Yu Wang, Lishun Liu, Ran Liu, Weiping Sun, Qing Peng and 12 more

Registry-linked trialOpen access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00794885 (Enalapril Maleate and Folic Acid Tablets for Primary Prevention of Stroke in Patients With Hypertension), which is not on this map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00794885 phase4completednot on this map

Enalapril Maleate and Folic Acid Tablets for Primary Prevention of Stroke in Patients With Hypertension: a Post-marketing, Double-blind, Randomized Controlled Trial.

TypeinterventionalSponsorShenzhen Ausa Pharmed Co.,LtdRan2008 to 2014Enrolled20,702ConditionsPrimary HypertensionArmsEnalapril/folic acid, Enalapril maleate
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Effect of perioperative blood pressure variability on cerebral hyperperfusion syndrome after carotid artery stenting: A retrospective study.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2022
    Article
  10. Transportation physical activity and new-onset hypertension: A nationwide cohort study in China.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 1 country.

Xi MenDepartment of Neurology, Peking University First Hospital, Beijing, China.
Wei SunDepartment of Neurology, Peking University First Hospital, Beijing, China.
Fangfang FanDepartment of Cardiology, Peking University First Hospital, Beijing, China.
Min ZhaoRenal Division, National Clinical Research Study Center for Kidney Disease, State Key Laboratory for Organ Failure Research, Southern Medical University Nanfang Hospital, Guangzhou, China.
Xiao HuangDepartment of Cardiology, Second Affiliated Hospital of Nanchang University, Nanchang, China.
Yu WangRenal Division, National Clinical Research Study Center for Kidney Disease, State Key Laboratory for Organ Failure Research, Southern Medical University Nanfang Hospital, Guangzhou, China.
Lishun LiuInstitute of Biomedicine, Anhui Medical University, Hefei, China.
Ran LiuDepartment of Neurology, Peking University First Hospital, Beijing, China.
Weiping SunDepartment of Neurology, Peking University First Hospital, Beijing, China.
Qing PengDepartment of Neurology, Peking University First Hospital, Beijing, China.
Xianhui QinRenal Division, National Clinical Research Study Center for Kidney Disease, State Key Laboratory for Organ Failure Research, Southern Medical University Nanfang Hospital, Guangzhou, China.
Genfu TangSchool of Health Administration, Anhui University, Hefei, China.
Jianping LiDepartment of Cardiology, Peking University First Hospital, Beijing, China.
Yan ZhangDepartment of Cardiology, Peking University First Hospital, Beijing, China.
Yefeng CaiDepartment of Neurology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Fan Fan HouRenal Division, National Clinical Research Study Center for Kidney Disease, State Key Laboratory for Organ Failure Research, Southern Medical University Nanfang Hospital, Guangzhou, China.
Binyan WangRenal Division, National Clinical Research Study Center for Kidney Disease, State Key Laboratory for Organ Failure Research, Southern Medical University Nanfang Hospital, Guangzhou, China.
Xiping XuRenal Division, National Clinical Research Study Center for Kidney Disease, State Key Laboratory for Organ Failure Research, Southern Medical University Nanfang Hospital, Guangzhou, China.
Xiaoshu ChengDepartment of Cardiology, Second Affiliated Hospital of Nanchang University, Nanchang, China.
Ningling SunDepartment of Cardiology, Peking University People's Hospital, Beijing, China.
Yining HuangDepartment of Neurology, Peking University First Hospital, Beijing, China ynhuang@sina.com huoyong@263.net.cn.
Yong HuoDepartment of Cardiology, Peking University First Hospital, Beijing, China ynhuang@sina.com huoyong@263.net.cn.
Peking University First Hospital · CNPeking University · CNNanfang Hospital · CNSouthern Medical University · CNAnhui Medical University · CNAnhui University · CNGuangdong Provincial Hospital of Traditional Chinese Medicine · CNNanchang University · CNSecond Affiliated Hospital of Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe optimal range of blood pressure variability remains unclear. We aimed to stratify the degree of risk of stroke based on visit-to-visit systolic blood pressure (SBP) variability in a large Chinese hypertensive population in 32 communities. METHODS AND

resultsWe retrospectively analyzed the data of 20 702 hypertensive patients from the China Stroke Primary Prevention Trial. The participants were randomized into 2 treatment groups to receive either enalapril or enalapril plus folic acid. Their blood pressures were measured every 3 months. The outcome was the first stroke. Three parameters of SBP variability were calculated: standard deviation, coefficient of variation, and average real variability. The records of first 4, 6, 8, 10 and 12 visits at which SBP was measured were used to calculate SBP variability and to predict subsequent stroke risk in adjusted Cox regression models. After median follow-up of 4.5 years, 597 patients had experienced stroke. Visit-to-visit SBP variability was an independent predictor of subsequent stroke (eg, the hazard ratio for the highest quintile of average real variability [22.67-61.07 mm Hg] over 6 visits was 1.55, 95% CI 1.07-2.25,

conclusionsVisit-to-visit SBP variability is an independent predictor of primary stroke in Chinese hypertensive patients. This predictive value depends on the number of blood pressure measurements used to calculate variability but is independent of mean SBP. CLINICAL

trial registrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT00794885.

Indexed as

Office VisitsAgedAntihypertensive AgentsBlood PressureBlood Pressure DeterminationChinaDouble-Blind MethodFemaleFollow-Up StudiesHumansHypertensionMaleMiddle AgedPrimary PreventionRetrospective StudiesRisk FactorsAntihypertensive Agentshypertensionstrokesystolic blood pressure variability

Identifiers

PMID28288974
PMCPMC5523997
OpenAlexW2596035162

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.